# SCRIMED Product And Services Portfolio Brief

Status: product-service-portfolio-upgrade-active
Updated: 2026-06-26
Offers: 10
Packages: 5
Margin controls: 8
Boundary resolutions: 6
Proof routes: 34

## Boundary
SCRIMED Product and Services Portfolio organizes sellable offers, service packages, delivery paths, proof routes, margin controls, qualification gates, and retained approval boundaries for governed synthetic evaluations, readiness work, protected pilots, and enterprise operating-layer expansion. It is product, service, and commercial operating readiness only. It is not legal advice, accounting advice, tax advice, audited financial reporting, securities offering material, investment advice, valuation assurance, customer permission, revenue guarantee, profit-margin guarantee, reimbursement assurance, clinical validation, compliance certification, security certification, PHI processing authority, production connector approval, EHR writeback approval, payer submission approval, or live clinical care authorization.

This brief is not legal advice, accounting advice, tax advice, audited financial reporting, securities offering material, investment advice, valuation assurance, customer permission, revenue guarantee, profit-margin guarantee, reimbursement assurance, clinical validation, compliance certification, security certification, PHI processing authority, production connector approval, EHR writeback approval, payer submission approval, or live clinical care authorization.

## Recommended Position
Use /offerings as the canonical packaging layer: every buyer conversation should resolve to one package, one offer, one proof route, one margin control, and one retained boundary before pricing or implementation expands.

## Revenue Path
- Assessment Package
- Readiness Sprint Package
- Synthetic Pilot Package
- Enterprise Activation Package
- Enterprise Operating Layer License
- Continuous Review Retainer

## Offers
- Workflow Intelligence Assessment (sellable-now, assessment): A fixed-scope workflow map, automation candidate scorecard, governance gap register, value-measurement plan, and next-package recommendation. Buyer: Health system operations, access, revenue-cycle, documentation, and transformation leaders. Boundary: Operational intelligence for human leaders only; no clinical advice, PHI processing, live care, or production automation approval.
- Health Records Safety Assessment (package-ready, assessment): A no-PHI extraction map, source-attribution plan, patient-safety lint checklist, standards crosswalk, and live-data approval path. Buyer: CMIO, clinical informatics, health information management, interoperability, privacy, and safety teams. Boundary: No-PHI extraction planning only; no patient matching, production connector use, EHR writeback, payer submission, or clinical action.
- Interoperability Readiness Sprint (package-ready, sprint): A connector readiness map, standard bindings, data-boundary decisions, synthetic conformance checks, and implementation sequence. Buyer: Integration, platform, IT, EHR, payer, data, and architecture teams. Boundary: Readiness and synthetic conformance only; production connector, PHI, security, and customer environment approval remain external gates.
- TrustOS AI Governance Audit (sellable-now, assessment): A governance gap report, claims register, model/workflow oversight map, audit evidence plan, and approval-gate ladder. Buyer: Compliance, privacy, legal, security, clinical governance, innovation, and executive AI oversight teams. Boundary: Governance readiness only; legal, regulatory, security, certification, and clinical authority require qualified external review.
- Synthetic Pilot Evaluation (sellable-now, pilot): A governed synthetic pilot with workflow packets, Trust Cards, QA evidence, operating metrics, proof routes, and protected-pilot recommendation. Buyer: Enterprise buyers ready to test governed workflow intelligence before live integration. Boundary: Synthetic evaluation only; no diagnosis, treatment, payer submission, patient outreach, live PHI, or production connector execution.
- Clinical Operations Automation Blueprint (protected-gated, sprint): A phased operating blueprint with workflow ownership, agent responsibilities, review queues, staffing assumptions, connector plan, and change-order triggers. Buyer: Clinical operations, transformation, care navigation, documentation, revenue-cycle, and public-sector program teams. Boundary: Blueprint planning only; protected pilot, live clinical authority, connectors, staffing, and production procedures require approved scope and controls.
- Enterprise Proof and Deal Room Activation (pilot-ready, retainer): A paid diligence and deal-room package that routes proof, access, recipient controls, release decisions, quote, SOW, data boundary, and next action. Buyer: Procurement, security, legal, executive sponsors, investor diligence, and enterprise buying committees. Boundary: Diligence activation only; buyer-specific external sharing, customer permission, security certification, signed contracts, and production activation remain gated.
- Global Certification Readiness Pack (external-review-required, sprint): A region-aware readiness packet that maps evidence, blocked claims, local review owners, deployment profile, procurement questions, and certification sequence. Buyer: Global health systems, sovereign programs, public-sector buyers, regional partners, and compliance teams. Boundary: Readiness-only global planning; local legal, privacy, security, certification, procurement, hosting, and clinical approvals remain external gates.
- Continuous Review and Innovation Retainer (package-ready, retainer): A retained operating cadence for agent-assisted review, issue routing, evidence updates, claims guard, incident learning, and internal innovation research assignments. Buyer: Enterprise sponsors, trust operations, governance teams, product leadership, and internal research stakeholders. Boundary: Agent-assisted and internal-research cadence only; humans approve remediation, public claims, production changes, and innovation disclosures.
- Enterprise Operating Layer License (external-review-required, enterprise-layer): A proposed annual operating license with workflow packages, implementation services, support tier, governance cadence, connector plan, and expansion gates. Buyer: Large health systems, payers, government health agencies, and multi-site healthcare organizations. Boundary: License proposal only until contracts, security, privacy, legal, finance, connector, support, and production authority are approved.

## Packages
- Assessment Package (entry): Fixed-fee package with capped workflows and no-PHI discovery.. Window: 2 to 4 weeks. Expansion: Synthetic Pilot Evaluation or Interoperability Readiness Sprint
- Readiness Sprint Package (growth): Scoped sprint with clear deliverables, owner map, and upgrade gates.. Window: 30 to 45 days. Expansion: Synthetic Pilot Evaluation or Enterprise Proof and Deal Room Activation
- Synthetic Pilot Package (enterprise): Paid synthetic pilot with workflow count, evidence cadence, and decision criteria.. Window: 45 to 90 days. Expansion: Protected Enterprise Pilot or Enterprise Operating Layer License
- Enterprise Activation Package (strategic): Enterprise proposal with license, implementation, diligence, support, and usage assumptions separated.. Window: 90 to 180 days depending on buyer controls. Expansion: Multi-year enterprise operating license or strategic platform partnership
- Continuous Review Retainer (retained): Monthly or quarterly retainer with human-approved review loops and separately scoped implementation work.. Window: Ongoing cadence. Expansion: Enterprise operating cadence, renewal health packet, or internal research roadmap

## Margin Controls
- Package before custom SOW (active-control): Map each opportunity to an approved package, included offers, excluded work, price floor, and expansion path before custom language leaves SCRIMED. Owner: Revenue operations + Product Console. Hard stops: custom SOW before package selected, unpriced implementation work, unsupported success fee
- Data-boundary price floor (human-review-required): Keep no-PHI work in standard packages; move sandbox, PHI, connector, or production work into separately reviewed paid scope. Owner: Finance + Legal Ops + Privacy. Hard stops: PHI requested, production connector requested, BAA/security scope missing
- Diligence work monetization (active-control): Price custom proof packets, evidence-room work, buyer-specific release review, and security questionnaire effort as paid diligence or activation scope. Owner: Buyer Diligence + Sales Operations. Hard stops: custom packet work without paid scope, external sharing before release decision, recipient controls missing
- License and services separation (active-control): Separate annual operating license, implementation services, connector work, training, support tier, and continuous review retainer on every enterprise proposal. Owner: Finance + Product + Implementation. Hard stops: services bundled into license, support tier undefined, implementation acceptance criteria missing
- Claims review before proof expansion (external-review-required): Keep external claims in readiness mode until buyer-approved baselines, customer permission, counsel review, finance review, and release decisions exist. Owner: Claims governance + Counsel + Finance. Hard stops: ROI guarantee, reimbursement guarantee, customer claim without permission, certification claim without authority
- Model cost and usage review (active-control): Attach usage assumptions, model routing, caching, volume thresholds, and overage review to pilots, retainers, and enterprise licenses. Owner: Product Engineering + Finance. Hard stops: uncapped high-volume usage, model-cost spike, usage threshold missing
- Global partner economics review (external-review-required): Route reseller, referral, sovereign, affiliate, regional hosting, and implementation partner economics through finance, tax, counsel, and delivery review. Owner: Strategic Partnerships + Finance + Tax + Regional Counsel. Hard stops: cross-border margin-sharing commitment, regional tax review missing, partner delivery owner missing
- Retainer escalation scope (human-review-required): Keep review loops, escalation routing, remediation, implementation, incident response, and innovation research as separate scope classes with approval gates. Owner: TrustOps + Product + Revenue Operations. Hard stops: autonomous remediation promised, managed SOC/MDR claim, implementation work hidden in retainer

## Boundary Resolutions
- Offer sprawl and buyer confusion (active-control): Route every buyer conversation to /offerings before pricing, pilot, diligence, or implementation scope expands. Remaining gate: Buyer-specific SOW, price, payment terms, and approval trail before commitment.
- Custom scope margin leakage (human-review-required): Offer a capped assessment, readiness sprint, synthetic pilot, or paid diligence package before custom SOW work. Remaining gate: Finance, legal, executive, and customer approval for custom scope and payment terms.
- Buyer asks for PHI, live records, connectors, EHR writeback, or payer submission (blocked-before-approval): Use synthetic fixtures, metadata-only system descriptions, sandbox planning, source attribution, and live-data gate mapping. Remaining gate: BAA/privacy/security approval, customer environment approval, clinical authority, connector acceptance, payer or EHR authorization as applicable.
- ROI, reimbursement, customer value, and revenue overclaim (external-review-required): Use measured pilot signals, directional workflow metrics, and readiness-only language until customer permission and qualified review exist. Remaining gate: Buyer-approved baseline, retained measurement evidence, customer permission, counsel review, finance review, and release decision.
- Certification, approval, and regional authority overclaim (external-review-required): Package readiness tracks, blocked claims, evidence gaps, and external-review owners without saying approval exists. Remaining gate: Qualified external authority, applicable audit or certification process, regional counsel, security/privacy review, and buyer-specific acceptance.
- Continuous review and innovation overclaim (human-review-required): Use agents to flag, route, recommend, and preserve evidence; keep humans in charge of changes and keep quantum research internal. Remaining gate: Human approval, security review, customer permission, evidence retention, and claims review before public or production use.

## Delivery Playbook
- Qualify: Classify buyer problem, urgency, sponsor, disqualifiers, data boundary, and best-fit package. Owner: Founder + Revenue Operations. Boundary: Qualification is not contract approval or clinical approval.
- Scope: Translate buyer need into offer, deliverables, assumptions, exclusions, owner map, and upgrade path. Owner: Product Console + Deal Desk. Boundary: Scope packet is not a signed SOW.
- Prove: Attach proof routes, synthetic evidence, QA controls, claims guard, and release boundaries. Owner: Sales Engineering + TrustOS + QA. Boundary: Proof is synthetic or readiness-only until protected evidence and customer permission exist.
- Convert: Move qualified buyer into quote-to-contract, paid diligence, pilot, or enterprise activation. Owner: Deal Desk + Finance + Legal Ops. Boundary: Conversion materials are not legal, accounting, tax, or audited financial advice.
- Expand: Use retained evidence, adoption signals, support load, safety review, and governance cadence to expand safely. Owner: Customer Operations + Product + TrustOps. Boundary: Expansion does not authorize production clinical use, customer public claims, or connector changes without approvals.

## Blocked Claims
- guaranteed revenue
- guaranteed ROI
- guaranteed profit margin
- audited financial reporting
- legal advice
- accounting advice
- tax advice
- securities offering material
- investment advice
- valuation assurance
- HIPAA certified
- SOC 2 certified
- HITRUST certified
- FDA cleared
- ONC certified
- GDPR compliant as a certified claim
- PHI processing approved
- production EHR connector approved
- EHR writeback approved
- payer submission approved
- autonomous diagnosis
- autonomous treatment
- live clinical care authorized
- public quantum capability
- medical advice
- guaranteed savings
- live workflow approval
- live PHI ingestion authorized
- patient matching approved
- production connector approved
- certified interoperability
- live PHI exchange approved
- legal approval
- regulatory approval
- security certification
- clinical validation
- production readiness approved
- customer value claim without permission
- live care authorized
- autonomous clinical workflow
- implementation approved without SOW
- customer permission granted
- external sharing approved
- security certification complete
- certified compliance
- regional legal approval
- government endorsement
- public-sector procurement approved
- error-free AI
- managed SOC/MDR
- autonomous remediation
- contract approved
- production authorized
- profit margin guaranteed
- custom scope approved without review
- implementation included by default
- discount approved
- ROI guaranteed
- reimbursement guaranteed
- revenue guaranteed
- customer value claim approved
- regional approval granted